[A trial of stimulation with tamoxifen of progesterone nuclear receptors in patients with kidney cancer].
Stimulation of progesterone receptors synthesis by Tamoxifen was tried in 19 patients with renal cell carcinoma. No difference was found between this series and 51 controls.